Literature DB >> 20392980

Factor analysis of behavioural symptoms in Huntington's disease.

Hugh Rickards1, Jenny De Souza, Marleen van Walsem, Erik van Duijn, Sheila A Simpson, Ferdinando Squitieri, Bernhard Landwehrmeyer.   

Abstract

A principal-components factor analysis was performed on behavioural data obtained from the European Huntington's Disease Network REGISTRY study. 1690 valid assessments using the United Huntington's Disease Rating Scale Behavioural Rating Scale were included in the analysis. This large data set confirmed previous reports of distinct behavioural patterns within Huntington's disease comprising a depressive factor, a dysexecutive factor, an irritability factor and a psychosis factor.

Entities:  

Mesh：

Year:  2010        PMID： 20392980     DOI： 10.1136/jnnp.2009.181149

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  11 in total

1.  Treatment of Apathy in Huntington's Disease and Other Movement Disorders.

Authors:  Ashok Krishnamoorthy; David Craufurd
Journal:  Curr Treat Options Neurol       Date:  2011-10       Impact factor: 3.598

2.  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.

Authors:  Eric A Epping; James A Mills; Leigh J Beglinger; Jess G Fiedorowicz; David Craufurd; Megan M Smith; Mark Groves; Kelly R Bijanki; Nancy Downing; Janet K Williams; Jeffrey D Long; Jane S Paulsen
Journal:  J Psychiatr Res       Date:  2013-06-19       Impact factor: 4.791

3.  Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.

Authors:  Xin Sun; Leonard O Marque; Zachary Cordner; Jennifer L Pruitt; Manik Bhat; Pan P Li; Geetha Kannan; Ellen E Ladenheim; Timothy H Moran; Russell L Margolis; Dobrila D Rudnicki
Journal:  Hum Mol Genet       Date:  2014-07-04       Impact factor: 6.150

4.  Unawareness of motor phenoconversion in Huntington disease.

Authors:  Elizabeth A McCusker; David G Gunn; Eric A Epping; Clement T Loy; Kylie Radford; Jane Griffith; James A Mills; Jeffrey D Long; Jane S Paulsen
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

5.  Risky business: factor analysis of survey data - assessing the probability of incorrect dimensionalisation.

Authors:  Cees van der Eijk; Jonathan Rose
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

6.  A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival.

Authors:  Tom Burke; Marta Pinto-Grau; Katie Lonergan; Peter Bede; Meabhdh O'Sullivan; Mark Heverin; Alice Vajda; Russell L McLaughlin; Niall Pender; Orla Hardiman
Journal:  Ann Clin Transl Neurol       Date:  2017-04-11       Impact factor: 4.511

7.  Irritability in Huntington's Disease: Factor Analysis of Snaith's Irritability Scale.

Authors:  John Maltby; Maria Dale; Mandy Underwood; Jane Simpson
Journal:  Mov Disord Clin Pract       Date:  2016-10-01

8.  The Spectrum of Psychiatric Pathology in a Patient with Genetically Verified Huntington's Disease.

Authors:  Samir Alkabie; Daljinder Singh; Amy Hernandez; Rhaisa Dumenigo
Journal:  Case Rep Psychiatry       Date:  2015-09-16

9.  Neuropsychiatry and White Matter Microstructure in Huntington's Disease.

Authors:  Sarah Gregory; Rachael I Scahill; Kiran K Seunarine; Cheryl Stopford; Hui Zhang; Jiaying Zhang; Michael Orth; Alexandra Durr; Raymund A C Roos; Douglas R Langbehn; Jeffrey D Long; Hans Johnson; Geraint Rees; Sarah J Tabrizi; David Craufurd
Journal:  J Huntingtons Dis       Date:  2015

10.  Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders.

Authors:  Karen E Anderson; Erik van Duijn; David Craufurd; Carolyn Drazinic; Mary Edmondson; Nathan Goodman; Daniel van Kammen; Clement Loy; Josef Priller; LaVonne Veatch Goodman
Journal:  J Huntingtons Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.